As Clasado Biosciences marks its 20th anniversary year, 2024 has been defined by significant achievements that have shaped both our business and the wider prebiotic category.
Looking back on twelve transformative months where our dedicated and expert team has gone from strength to strength, we’re proud to share a snapshot of the highlights that have made this celebration year so special.
Celebrating two decades of excellence
2024 marked a significant milestone as we celebrated 20 years of prebiotic innovation. From our research origins to our current position as a global leader in prebiotic science, this journey reflects our unwavering commitment to scientific excellence – as well as the growing demand for gut health solutions worldwide.
The anniversary has been a time to recognise not just our achievements, but also the dedication of our team across every department – from research and development to operations, quality control, regulatory affairs and commercial development. The whole team’s collaborative spirit and shared commitment to excellence have been instrumental in shaping Clasado into the company it is today.
Global expansion and market growth
2024 has been a landmark year for expanding access to Bimuno® GOS. Our partnership with Alliance Group marked a strengthened presence in China, while new partnerships with distributors such as BART in Poland have supported an increased European presence.
Regulatory prowess
Bimuno GOS now has access to over 80 health claims globally, with further expansion anticipated in 2025. We’ve achieved important regulatory milestones, including the registration of Bimuno GOS powder in Vietnam, making our prebiotic ingredient more accessible to formulators worldwide. In addition, 10 Health Canada claims were secured for Bimuno Syrup, giving formulators in North America the flexibility to use either Bimuno powder or syrup formats in their applications whilst allowing the use of validated health claims on pack to secure consumer confidence through product effectiveness.
Scientific excellence and recognition
Our commitment to advancing and sharing prebiotic science reached new heights in 2024. The research portfolio behind Bimuno GOS reached 125 scientific publications including 26 clinical trials, reinforcing its position as the most studied galactooligosaccharide prebiotic commercially available. A significant scientific development was the publication of our collaborative study with Probi AB in the International Journal of Nutritional Sciences, which demonstrated one of the first verified synergistic effects in a commercially available synbiotic combination.
Our dedication to sharing scientific insights took centre stage throughout the year. We presented findings at prestigious events including Digestive Disease Week®, where our synbiotic research garnered significant attention from healthcare professionals and gastroenterology experts. Our CEO, Per Rehné, shared valuable insights at Phytonet’s inaugural ‘Innovate. Integrate. Inspire.’ event, while our joint webinar with Probi AB helped educate formulators about the potential of science-backed synbiotics.
The appointment of our R&D Director, Dr. Lucien Harthoorn, to the ILSI Europe Board of Directors further demonstrated our commitment to nutrition science. Our dedication to excellence was also recognised at the Natural Choice Awards, where we secured gold for Microbiome Support in the Ingredients Edition, underscoring our leading role in the growing ‘biotics’ category.
New markets and innovations
In a significant strategic expansion, we entered the pet nutrition sector with the launch of Bimuno Pet, applying our two decades of prebiotic expertise to the rapidly growing companion animal health market.
This move reflects our commitment to exploring new applications for our proven prebiotic technology, applying key concepts and knowledge from human nutrition across to animal health.
The year also saw exciting developments in product applications, particularly in the beverage sector. The stability and versatility of Bimuno GOS makes it an ideal choice for prebiotic beverages, especially as consumer demand grows for functional drinks that offer more than just refreshment. With the ready-to-drink (RTD) category continuing to expand, prebiotic-enhanced beverages represent a significant opportunity for formulators to meet evolving consumer needs through convenient, science-backed formats – with Clasado ready to support customers aiming to reach this market.
Industry engagement and education
Throughout 2024, we maintained our commitment to industry education and engagement. We participated in major events including ISAPP’s Annual Meeting, Gira Ingredients Club and Dairy Club, SupplySide West, and numerous international trade shows such as Fi Europe in Frankfurt, Vitafoods Asia in Bangkok, and Food Ingredients China in Shanghai. These platforms provided valuable opportunities to share our expertise and connect with partners and customers globally.
Adding to our operational excellence, we secured ISO 9001:2015 accreditation for Quality Management Systems from LRQA – a testament to our systematic approach to quality management.
Looking ahead
As we close our 20th anniversary year, our team remains committed to pushing the boundaries of prebiotic science and innovation. The rapid growth in consumer understanding of gut health, combined with expanding applications for prebiotics in areas such as sports nutrition, immune health and pet nutrition, points toward exciting opportunities ahead.
For formulators looking to develop next-generation health and nutrition products, there has never been a better time to explore the potential of prebiotics. With our expanded global presence, growing scientific portfolio, and continued focus on innovation, we’re perfectly positioned to support your product development needs in 2025 and beyond.
